WebFeb 4, 2014 · Jab1/CSN5 is a multifunctional protein that plays an important role in integrin signaling, cell proliferation, apoptosis, and the regulation of genomic instability and DNA repair. ... Given the prominent antineoplastic potential of Jab1, the development of specific, effective, and safe Jab1/CSN5 inhibitors is likely to have a significant impact ... WebJAB1/CSN5 inhibits the activity of Luman/CREB3 by promoting its degradation
CSN5i-3 is a potent inhibitor of CSN5-catalysed cullin …
WebNov 10, 2024 · To investigate the effects of CSN5 on thyroid carcinoma carcinogenesis in vivo, we used a tumorigenicity assay with nude mice, and measured tumor volumes after injecting them with transfected cells. As shown in Fig. 2C and 2D, the subdermal tumors of the CSN5-silenced group showed a lower weight and smaller volume than those of the … WebCSN5i-3 (CSN5 inhibitor 3) is a potent, selective and orally available inhibitor of CSN5 with IC50 of 5.8 nM, the proteolytic subunit of COP9 signalosome (CSN). Get Quotation Now * Please select Quantity before adding items. or Bulk Inquiry Bulk size, bulk discount! E-mail: [email protected] Tech Support: [email protected] crosswinds slate grey vanity
CSN5 Promotes Carcinogenesis of Thyroid Carcinoma Cells …
WebMar 14, 2024 · Whereas CSN5 induces deNEDDylation by cleaving NEDD8 conjugates from the cullin subunit of CRLs , the pharmacological inhibitor MLN4924 inhibits NEDDylation by inhibiting the NEDD8-activating enzyme E1 (NAE) . Hence, MLN4924 activity, at least in part, mirrors effects afforded by the overexpression or up-regulation of CSN5, although … WebJul 12, 2024 · CSN5, a member of Cop9 signalosome, is essential for protein neddylation. It has been supposed to serve as an oncogene in some cancers. However, the role of CSN5 has not been investigated in cervical cancer yet. ... MLN4924 (pevonedistat) is a small molecular inhibitor that effectively disrupts neddylation by targeting NEDD8-activating … WebMar 1, 2015 · CSN5 has been implicated as a candidate oncogene in human cancers by genetic linkage with activation of the poor-prognosis, wound response gene expression … build back better global agenda